Decreased Bone Mineral Density with Off-Label Use of Tenofovir in Children and Adolescents Infected with Human Immunodeficiency Virus
- 30 April 2008
- journal article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 152 (4), 582-584
- https://doi.org/10.1016/j.jpeds.2007.12.020
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy: Impact on Bone Mineral Density in HIV-Infected ChildrenPublished by American Academy of Pediatrics (AAP) ,2006
- A 12-Month Treatment With Tenofovir Does Not Impair Bone Mineral Accrual in HIV-Infected ChildrenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Tenofovir Disoproxil Fumarate and an Optimized Background Regimen of Antiretroviral Agents as Salvage Therapy for Pediatric HIV InfectionPediatrics, 2005
- Single-Dose and Steady-State Pharmacokinetics of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected ChildrenAntimicrobial Agents and Chemotherapy, 2004
- National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines for Chronic Kidney Disease in Children and Adolescents: Evaluation, Classification, and StratificationPediatrics, 2003
- Bone Mineral Acquisition in Healthy Asian, Hispanic, Black, and Caucasian Youth: A Longitudinal Study1Journal of Clinical Endocrinology & Metabolism, 1999
- Bone Mineral Acquisition in Healthy Asian, Hispanic, Black, and Caucasian Youth: A Longitudinal StudyJournal of Clinical Endocrinology & Metabolism, 1999
- Bone Densitometry in Canadian Children 8–17 Years of AgeCalcified Tissue International, 1996